T2T@PSU: Tweens to Teens Project at Penn State

Sponsor
Penn State University (Other)
Overall Status
Completed
CT.gov ID
NCT01184651
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
188
1
47
4

Study Details

Study Description

Brief Summary

The goal of this study is to help investigators to understand more about the development of characteristics related to being male or female (what is called gender development). The investigators will study girls with congenital adrenal hyperplasia (CAH) aged 10 to 13 to learn more about the girls' interests and activities, thoughts and feeling about being female, and family relationships. This will help investigators to understand the ways in which gender development is shaped by hormones and family relationships.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Questionnaires/Interviews
  • Behavioral: Questionnaires/Interviews

Detailed Description

Interviewers will visit girls in their home when it is convenient for the family. Girls will answer questions about the things they do and are interested in, how they think and feel, and complete some cognitive tasks. Girls will also provide saliva so we can examine their hormones and determine the CAH gene mutation they have. Parents will also be asked to complete questionnaires about their own activities and interests and about their daughter's behavior.

Shortly after the home visit, interviewers will telephone girls and their parents on several days and ask what the girls did during the day.

Study Design

Study Type:
Observational
Actual Enrollment :
188 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
"Gender Development in Early Adolescence: Prenatal Hormones and Family Socialization"
Study Start Date :
Aug 1, 2009
Actual Primary Completion Date :
Jul 1, 2013
Actual Study Completion Date :
Jul 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Girls

Girls with 21-hydroxylase deficiency (21-OHD) congenital adrenal hyperplasia (CAH) ages 10-13

Behavioral: Questionnaires/Interviews
Girls answer questions about activities and interests, school, feelings about being a girl, stage of physical development, and family relationships during a home interview , provide saliva samples, and participate in phone interviews to answer questions about daily activities .

Parents

Parent, guardian, or significant caretaker of girls with CAH

Behavioral: Questionnaires/Interviews
Parents complete questionnaires about their daughter's activities, interests, and behaviors, educational goals, family demographics and relationships, grades, diagnosis and treatment of her CAH, their own activities, interests, and thoughts and feelings about being male or female. Parents answer questions during phone interviews about their daughters daily activities.

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 13 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Girls with classical or non-classical CAH due to 21-OHD

    • Girls will be aged 10-13 years at initial recruitment

    • Parents will include biological mothers and fathers as well as step-parents and/or other guardians/significant caregivers

    • Parents/guardians may range in age from 18 years of age to 65 years of age.

    Exclusion Criteria:
    • Girls who are not within the age range of 10-13 years old at initial recruitment

    • CAH not due to the 21-OHD form

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Pennsylvania State University, Dept. of Psychology - Tweens to Teens Project University Park Pennsylvania United States 16802

    Sponsors and Collaborators

    • Penn State University
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Investigators

    • Principal Investigator: Sheri A Berenbaum, PhD, The Pennsylvania State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sheri Berenbaum, Professor of Psychology and Pediatrics, Penn State University
    ClinicalTrials.gov Identifier:
    NCT01184651
    Other Study ID Numbers:
    • PSU ORP#30695
    • 1R01HD057930-01A1
    First Posted:
    Aug 19, 2010
    Last Update Posted:
    Jan 8, 2018
    Last Verified:
    Jan 1, 2018
    Keywords provided by Sheri Berenbaum, Professor of Psychology and Pediatrics, Penn State University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 8, 2018